223
Views
24
CrossRef citations to date
0
Altmetric
Reviews

Inclusion body myositis: from immunopathology and degenerative mechanisms to treatment perspectives

&
Pages 1125-1133 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (23)

Colin Quinn, Kelsey MoultonMichael FarwellWilliam LeIan WilsonNiti GoelJonathan McConathySteven A. Greenberg. (2023) Imaging With PET/CT of Diffuse CD8 T-Cell Infiltration of Skeletal Muscle in Patients With Inclusion Body Myositis. Neurology 101:11.
Crossref
Katja C. Senn, Simone Thiele, Karsten Kummer, Maggie C. Walter & Klaus H. Nagels. (2023) Patient-Reported Health-Related Quality of Life, Anxiety and Depression in Patients with Inclusion Body Myositis: A Register-Based Cross-Sectional Study in Germany. Journal of Clinical Medicine 12:15, pages 5051.
Crossref
Marinos C. Dalakas. 2023. Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders. Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders 425 460 .
Didier Laurent, Jon RiekChristopher D.J. Sinclair, Parul Houston, Ronenn RoubenoffDimitris A. PapanicolaouAttila Nagy, Steve Pieper, Tarek A. YousryMichael G. HannaJohn S. Thornton & Pedro M. Machado. (2022) Longitudinal Changes in MRI Muscle Morphometry and Composition in People With Inclusion Body Myositis. Neurology 99:9.
Crossref
Namita A. GoyalGérald CoulisJorge DuartePhilip K. FarahatAli H. MannaaJonathan CauchiiTyler IraniNadia AraujoLeo WangMarie WencelVivian LiLishi ZhangSteven A. GreenbergTahseen MozaffarS. Armando Villalta. (2022) Immunophenotyping of Inclusion Body Myositis Blood T and NK Cells. Neurology 98:13.
Crossref
Marinos C. Dalakas. 2022. Acquired Neuromuscular Disorders. Acquired Neuromuscular Disorders 107 121 .
Udo Schneider, Werner Stenzel & Bruno Stuhlmüller. (2021) Biomarker und Histologie bei idiopathischen inflammatorischen Myopathien. Aktuelle Rheumatologie 46:04, pages 343-360.
Crossref
Jiri Vencovsky. 2020. Managing Myositis. Managing Myositis 37 46 .
Steven A. Greenberg. (2019) Inclusion body myositis: clinical features and pathogenesis. Nature Reviews Rheumatology 15:5, pages 257-272.
Crossref
Carrie J. Finno, Giuliana Gianino, Sudeep Perumbakkam, Zoë J. Williams, Matthew H. Bordbari, Keri L. Gardner, Erin Burns, Sichong Peng, Sian A. Durward-Akhurst & Stephanie J. Valberg. (2018) A missense mutation in MYH1 is associated with susceptibility to immune-mediated myositis in Quarter Horses. Skeletal Muscle 8:1.
Crossref
Rishibha Sachdev, Karin Kappes-Horn, Lydia Paulsen, Yvonne Duernberger, Catharina Pleschka, Philip Denner, Bishwajit Kundu, Jens Reimann & Ina Vorberg. (2018) Endoplasmic Reticulum Stress Induces Myostatin High Molecular Weight Aggregates and Impairs Mature Myostatin Secretion. Molecular Neurobiology 55:11, pages 8355-8373.
Crossref
Karsten Schmidt & Jens Schmidt. (2017) Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment. Current Opinion in Rheumatology 29:6, pages 632-638.
Crossref
Christian W. Keller, Jens Schmidt & Jan D. Lünemann. (2017) Immune and myodegenerative pathomechanisms in inclusion body myositis. Annals of Clinical and Translational Neurology 4:6, pages 422-445.
Crossref
Sabrina Anh-Tu Hoa & Marie Hudson. (2017) Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies. Seminars in Arthritis and Rheumatism 46:4, pages 488-508.
Crossref
Anna Postolova, Jennifer K. Chen & Lorinda Chung. (2016) Corticosteroids in Myositis and Scleroderma. Rheumatic Disease Clinics of North America 42:1, pages 103-118.
Crossref
Marinos C. Dalakas. 2016. Acquired Neuromuscular Disorders. Acquired Neuromuscular Disorders 83 98 .
Inka Albrecht, Cecilia Wick, ?sa Hallgren, Anna Tj?rnlund, Kanneboyina Nagaraju, Felipe Andrade, Kathryn Thompson, William Coley, Aditi Phadke, Lina-Marcela Diaz-Gallo, Matteo Bottai, Inger Nennesmo, Karine Chemin, Jessica Herrath, Karin Johansson, Anders Wikberg, A. Jimmy Ytterberg, Roman A. Zubarev, Olof Danielsson, Olga Krystufkova, Jiri Vencovsky, Nils Landegren, Marie Wahren-Herlenius, Leonid Padyukov, Olle K?mpe & Ingrid E. Lundberg. (2015) Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. Journal of Clinical Investigation 125:12, pages 4612-4624.
Crossref
A. David Paltiel, Einar Ingvarsson, Donald K. K. Lee, Richard L. Leff, Richard J. Nowak, Kurt D. Petschke, Seth Richards-Shubik, Ange Zhou, Martin Shubik & Kevin C. O'Connor. (2015) Demographic and clinical features of inclusion body myositis in north America. Muscle & Nerve 52:4, pages 527-533.
Crossref
Ingrid E. Muth, Jana Zsch?ntzsch, Konstanze Kleinschnitz, Arne Wrede, Ellen Gerhardt, Peter Balcarek, Olivia Schreiber-Katz, Stephan Zierz, Marinos C. Dalakas, Reinhard E. Voll & Jens Schmidt. (2015) HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis. Experimental Neurology 271, pages 189-197.
Crossref
Olivier Benveniste, Werner Stenzel, David Hilton-Jones, Marco Sandri, Olivier Boyer & Baziel G. M. van Engelen. (2015) Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathologica 129:5, pages 611-624.
Crossref
Valerie Askanas, W. King Engel & Anna Nogalska. (2015) Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1852:4, pages 633-643.
Crossref
Stefen Brady, Estelle G Healy, Pedro Machado, Matt Parton, Janice L Holton & Mike G Hanna. (2014) Inclusion body myositis: clinical review and current practice. Clinical Practice 11:6, pages 623-637.
Crossref
Marinos C. Dalakas. (2014) Mechanistic Effects of IVIg in Neuroinflammatory Diseases: Conclusions Based on Clinicopathologic Correlations. Journal of Clinical Immunology 34:S1, pages 120-126.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.